Michael Mullan is a biomedical researcher of the β-amyloid protein and its relation to Alzheimer’s disease. Mullan's Alzheimer research is well known among Biomedical Community. Dr. Mullan's Alzheimer research work [1] resulted in identifying the most widely known Swiss Mutation that is present in familial form. Transgenic Animal for Alzheimer Disease uses Swiss Mutation.
Dr. Mullan is currently the director[2] of the Roskamp Institute in Sarasota, Florida. Under Dr. Mullan's guidelines the institute is carrying out cutting edge research in Alzheimer's, Traumatic Brain Research, Gulf War Illness and other neuropsychiatric disorder.